Its protein expression level is increased in many human cancers such as hepatocarcinomas, digestive adenocarcinomas and ovarian cancers, and its downregulation in p53- and RB-compromised cancer cells can trigger their senescence.1 Further understanding of E2F1 expression regulation would help to develop strategies targeting this protein in cancer cells. This evidence concerns the gene RB1 and cancer.